Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Serum CD44 Variant 6 to CD44 Ratio and Vascular Endothelial Growth Factor Levels as Predictors of Metastasis in Luminal Subtype Breast Cancer

The Indonesian Biomedical Journal · Vol. 17 No. 3 (2025) · hlm. 263–272

DOI
10.18585/inabj.v17i3.3586
ISSN
2085-3297, 2355-9179
Terbit
2025-06-17
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Metastasis is the leading cause of mortality in luminal subtype breast cancer. While cluster of differentiation (CD)44 has been widely studied, the prognostic relevance of its isoforms particularly the CD44v6/CD44s ratio remains unclear. This study evaluates CD44v6, CD44s, vascular endothelial growth factor (VEGF), and the CD44v6/CD44s ratio as potential prognostic biomarkers for metastasis in luminal breast cancer.METHODS: This case-control study included 38 luminal subtype breast cancer patients (18 with metastasis, 20 without metastasis). Serum levels of CD44v6, CD44s, VEGF, and the CD44v6/CD44s ratio were measured using Enzyme-Linked Immunosorbent Assay (ELISA). Statistical analyses included ROC analysis to determine optimal cut-off points, logistic regression to assess risk factors, and correlation analysis for biomarker relationships.RESULTS: A low CD44v6/CD44s ratio (<0.03) was identified as a significant independent factor for metastasis (adjusted OR 7.0, 95% CI: 1.2–40.6, p=0.03). While serum levels of CD44v6, CD44s, and VEGF were higher in the metastasis group, these individual markers showed a non-significant trend toward association with metastasis. A strong positive correlation was observed between CD44s and VEGF levels (r=0.7, p<0.01).CONCLUSION: The CD44v6/CD44s ratio showed a significant association with metastasis and may have potential as a prognostic marker in luminal breast cancer. Further studies with larger sample sizes are needed to confirm these findings.KEYWORDS: CD44v6, CD44s, VEGF, CD44v6/CD44s ratio, luminal breast cancer, metastasis

Kata kunci

Jaringan kolaborasi para penulis

33 penulis · 138 tautan kepenulisan bersama · 25 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Udayana University
  • National Cheng Kung University
  • Universitas Gadjah Mada
  • National Research and Innovation Agency
  • State University of Semarang
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
I Wayan NiryanaUdayana University3
I Made JawiUdayana University3
Ida Bagus Made SuryawisesaUdayana University2
I Wayan Putu Sutirta YasaUdayana University2
I Nyoman Wawan Tirtha YasaUdayana University2
Ni Putu SriwidyaniUdayana University2
Wayan Tunas ArtamaUniversitas Gadjah Mada1
Didik Tulus SubektiNational Research and Innovation Agency1
Nico Odolf YordaniusUdayana University1
I Ketut WiargithaUdayana University1
Nyoman GoldenUdayana University1
I Wayan PeriadijayaUdayana University1
Anak Agung Ngurah Jaya KusumaUdayana University1
Anom SuardikaUdayana University1
Ni Gusti Ayu Manik ErmayantiUdayana University1
Endang Sri WidiyantiUdayana University1
I Gusti Ngurah Agung Satria WibawaUdayana University1
Divika SilvanaUdayana University1
Anak Agung Gede Raka BudayasaAfiliasi tidak diketahui1
H. Sunny SunNational Cheng Kung University1
Yen‐An TangNational Cheng Kung University1
Bambang PurwantoState University of Semarang1
Yenny KandariniUdayana University1
Ni Wayan WinartiUdayana University1
Ketut SuegaUdayana University1
I Gde Raka WidianaUdayana University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Serum CD44 Variant 6 to CD44 Ratio and Vascular Endothelial Growth Factor Levels as Predictors of Metastasis in Luminal Subtype Breast Cancer</dc:title><dc:creator>Ni Putu Yenny Kendarini</dc:creator><dc:creator>Ida Bagus Tjakra Wibawa Manuaba</dc:creator><dc:creator>I Wayan Sudarsa</dc:creator><dc:creator>Tjokorda Gde Bagus Mahadewa</dc:creator><dc:creator>Ni Nyoman Ayu Dewi</dc:creator><dc:creator>Prayuda Prayuda</dc:creator><dc:creator>Putu Febry Krisna Pertiwi</dc:creator><dc:subject>luminal breast cancer</dc:subject><dc:subject>metastasis</dc:subject><dc:subject>CD44v6</dc:subject><dc:subject>CD44</dc:subject><dc:subject>vascular endothelial growth factor</dc:subject><dc:subject>prognostic factors</dc:subject><dc:subject>serum biomarkers</dc:subject><dc:subject>metastasis risk prediction</dc:subject><dc:description xml:lang="en">BACKGROUND: Metastasis is the leading cause of mortality in luminal subtype breast cancer. While cluster of differentiation (CD)44 has been widely studied, the prognostic relevance of its isoforms particularly the CD44v6/CD44s ratio remains unclear. This study evaluates CD44v6, CD44s, vascular endothelial growth factor (VEGF), and the CD44v6/CD44s ratio as potential prognostic biomarkers for metastasis in luminal breast cancer.METHODS: This case-control study included 38 luminal subtype breast cancer patients (18 with metastasis, 20 without metastasis). Serum levels of CD44v6, CD44s, VEGF, and the CD44v6/CD44s ratio were measured using Enzyme-Linked Immunosorbent Assay (ELISA). Statistical analyses included ROC analysis to determine optimal cut-off points, logistic regression to assess risk factors, and correlation analysis for biomarker relationships.RESULTS: A low CD44v6/CD44s ratio (&lt;0.03) was identified as a significant independent factor for metastasis (adjusted OR 7.0, 95% CI: 1.2–40.6, p=0.03). While serum levels of CD44v6, CD44s, and VEGF were higher in the metastasis group, these individual markers showed a non-significant trend toward association with metastasis. A strong positive correlation was observed between CD44s and VEGF levels (r=0.7, p&lt;0.01).CONCLUSION: The CD44v6/CD44s ratio showed a significant association with metastasis and may have potential as a prognostic marker in luminal breast cancer. Further studies with larger sample sizes are needed to confirm these findings.KEYWORDS: CD44v6, CD44s, VEGF, CD44v6/CD44s ratio, luminal breast cancer, metastasis</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2025-06-17</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v17i3.3586</dc:identifier><dc:identifier>10.18585/inabj.v17i3.3586</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 17 No 3 (2025); 263-272</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/3586/776</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>